MedPath

Evaluating the efficacy of N-acetyl cysteine (NAC) in dyspeptic patients and negative Helicobacter pylori infectio

Not Applicable
Recruiting
Conditions
dyspepsia.
Functional dyspepsia
Registration Number
IRCT20170716035126N3
Lead Sponsor
Ardabil University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
88
Inclusion Criteria

Patients with the complaint of dyspepsia and negative H. pylori test

Exclusion Criteria

Chronic use of NSAIDs or corticosteroids fro more than a month
Gastric outlet obstruction diagnosed in endoscopy
Pregnancy (due to the side effects)
Chronic kidney disease
GI malignancy
previous gastric surgery
Patients receiving NAC due to asthma or COPD

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Dyspepsia symptoms. Timepoint: Before and 8 weeks after intervention. Method of measurement: Using ROME III criteria.;Need for endoscopy. Timepoint: 8 weeks after intervention. Method of measurement: No change or deterioration of dyspepsia symptoms.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath